Latest News and Press Releases

60 Degrees Pharma reports 223% YoY revenue growth in Q3 2025; advances babesiosis programs with Tulane, Mount Sinai, and MUMS canine designation plans.

PORTOLA VALLEY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, the leading nonprofit funder of Lyme disease research in the US, today announced results from two independent...

60 Degrees Pharma unveils “B-FREE” Phase 2 trial for chronic babesiosis, engaging patients in naming and supporting Lyme research groups.

New York, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight According to DelveInsight’s analysis,...

PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the launch of Bay Area Lyme Ventures (Lyme...

60 Degrees and Tulane to study tafenoquine against Lyme and Bartonella bacteria, part of the “3Bs” common in tick-borne illness co-infections.

The new research, published in Frontiers in Medicine, points to the need for greater follow-up from medical professionals to address potential treatment failures. PORTOLA VALLEY, Calif., July 10,...

PORTOLA VALLEY, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has hired Josh Wein to serve as its new executive director,...

PORTOLA VALLEY, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has given its 2025 Emerging Leader Award (ELA) to Chao Wang,...

Clinical & Laboratory Standards Institute is partnering with LymeX Diagnostics Prize to accelerate the development of Lyme disease detection and treatment.